Drug Manufacturers—General

Rubicon Research Reports 52% Revenue Growth in Q3 FY26; Profit Nearly Doubles

● Feb 3, 2026

Rubicon Research Limited (NSE: RUBICON) shares were trading higher following the release of its Q3 FY26 earnings, though stock price...

Gland Pharma Limited (GLAND) Q2 FY23 Earnings Concall Transcript

● Oct 26, 2022

Gland Pharma Limited (NSE:GLAND) Q2 FY23 Earnings Concall dated Oct. 26, 2022 Corporate Participants: Sumanta Bajpayee — Vice President, Corporate Finance and...

Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript

● Jul 21, 2022

Gland Pharma Limited (NSE: GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee — Vice President, Corporate Finance...